Mortality in IMPACT: Confounded by Asthma?
- PMID: 32396735
- PMCID: PMC7462402
- DOI: 10.1164/rccm.202004-1159LE
Mortality in IMPACT: Confounded by Asthma?
Comment in
-
Reply to Suissa: Mortality in IMPACT: Confounded by Asthma?Am J Respir Crit Care Med. 2020 Sep 1;202(5):773-774. doi: 10.1164/rccm.202004-1399LE. Am J Respir Crit Care Med. 2020. PMID: 32396736 Free PMC article. No abstract available.
Comment on
-
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508-1516. doi: 10.1164/rccm.201911-2207OC. Am J Respir Crit Care Med. 2020. PMID: 32162970 Free PMC article. Clinical Trial.
References
-
- Suissa S, Drazen JM. Making sense of triple inhaled therapy for COPD. N Engl J Med. 2018;378:1723–1724. - PubMed
-
- Suissa S, Ariel A. Triple therapy trials in COPD: a precision medicine opportunity. Eur Respir J. 2018;52:1801848. - PubMed
-
- Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332–336. - PubMed
